Nick Sutcliffe - August 13, 2024 Cellular agriculture – increasing importance of IP in cultivated meat As the cultivated meat industry matures, consolidation is widely anticipated due to increasing ...
Joanna Smith - June 10, 2024 Mewburn Ellis ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent Practitioners 2024 We are delighted to once again be ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent ...
Nick Sutcliffe - March 4, 2024 Cellular Agriculture – Innovating through the Challenges The last year (2023) has seen a difficult environment for Cellular Agriculture (Cell Ag) companies ...
Nick Sutcliffe - October 3, 2023 Covid autumn booster vaccine 2023: the switch to mono-valent vaccines Autumn 2023 sees another round of COVID-19 booster jabs across the UK for vulnerable people.
Nick Sutcliffe - July 26, 2023 IP priorities for forward-looking cell and gene therapy businesses IP priorities are especially important to businesses developing advanced therapeutic products. ...
Nick Sutcliffe - July 6, 2023 VC tips for SMEs — how much equity should a start-up give away in a Series A fundraising? As part of a series in which we ask leading venture capitalists to answer a question of fundamental ...
Nick Sutcliffe - July 6, 2023 VC tips for SMEs — how to choose the right VC? As part of a series in which we ask leading venture capitalists to answer a question of fundamental ...
Joanna Smith - July 4, 2023 Mewburn Ellis ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent Practitioners 2023 We are delighted to once again be ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent ...
Adam Gregory - June 22, 2023 Cell-cultivated chicken approved for sale in US On Wednesday 21 June 2023, the United States Department of Agriculture (USDA) approved the sale of ...
Nick Sutcliffe - December 20, 2022 mRNA cancer vaccine shows efficacy in clinical trial Moderna and Merck announced in a mid-December 2022 press release that its mRNA cancer vaccine ...
Jacqueline Murphy - July 4, 2022 Mewburn Ellis ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent Practitioners 2022 We are delighted to once again be ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent ...
Jacqueline Murphy - June 20, 2022 Mewburn Ellis ranked Tier 1 for Patent prosecution in MIP IP STARS 2022 We are delighted to once again be ranked Tier 1 for Patent Prosecution UK in MIP IP STARS 2022.
Jacqueline Murphy - July 2, 2021 IAM Patent 1000: The World’s Leading Patent Professionals 2021 We are delighted to once again be ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent ...
Jacqueline Murphy - June 17, 2021 Mewburn Ellis ranked Tier 1 for Patent prosecution in MIP IP STARS 2021 We are delighted to be ranked Tier 1 for Patent Prosecution UK in MIP IP STARS 2021. As one of only ...
Nick Sutcliffe - May 14, 2021 IP for forward-looking life sciences businesses The recently released Mewburn Ellis IP Guide for SMEs sets out IP priorities for businesses at four ...
Nick Sutcliffe - November 25, 2020 AstraZeneca/Oxford University vaccine shows efficacy against SARS-CoV-2 AstraZeneca/Oxford University have announced that their SARS-CoV-2 candidate vaccine AZD1222 showed ...
Nick Sutcliffe - November 16, 2020 And then there were two – Moderna SARS-CoV-2 vaccine shows efficacy Moderna have announced that their SARS-CoV-2 vaccine candidate mRNA1273 showed efficacy in a first ...
Nick Sutcliffe - November 13, 2020 Pfizer and BioNTech vaccine provides protection against SARS-CoV-2 Pfizer/BioNTech have now released more data from the Phase 3 clinical trial of the BNT162b2 ...
Nick Sutcliffe - October 21, 2020 Liquid biopsies support precision medicine The treatment of cancer patients with therapies that are specifically targeted to their cancer is a ...
Nick Sutcliffe - September 22, 2020 Making the detection of cancer in liquid biopsies more sensitive Besides being found within the nucleus and mitochondria of cells, DNA is also present in ...
Nick Sutcliffe - September 11, 2020 Pepper decision means conventionally bred plants and animals get a chilli reception at the EPO Dr Ben Tolley and Dr Nick Sutcliffe of the Life Sciences team look at the extensive ramifications ...
Nick Sutcliffe - June 29, 2020 Supreme Court confirms strict line on insufficiency in the UK On 24 June 2020, the UK Supreme Court (UKSC) confirmed the UK courts’ strict approach to sufficient ...
Jacqueline Murphy - June 16, 2020 IAM Patent 1000: The World’s Leading Patent Professionals 2020 We are delighted to once again be ranked ‘highly recommended’ in ‘IAM 1000: The World’s Leading ...
Nick Sutcliffe - May 19, 2020 G3/19 The Enlarged Board of Appeal has its cake and eats it On 14 May 2020, the Enlarged Board of Appeal of the European Patent Office (EBA) released their ...
Jacqueline Murphy - May 5, 2020 IP STARS 2020: The leading practitioners in IP Congratulations to Sofia Arenal, Chris Denison, Stephen Gill, Sean Jauss, Kate O’Rourke, Nick ...
Nick Sutcliffe - February 18, 2020 The evolutionary history of cancer - predicting the disease Cells can acquire the mutations that drive the development of cancer many years before the patient ...
Nick Sutcliffe - October 21, 2019 Controlling genes – the new field of epitranscriptomics The human genome contains roughly 20,000 genes that encode proteins. In order for the cells and ...
Nick Sutcliffe - August 29, 2019 Shifting treatments: cancer as a manageable disease As new treatments drive a shift towards treating cancer as a manageable disease we are seeing ...
Jacqueline Murphy - June 17, 2019 Managing Intellectual Property: IP Stars 2019 We are delighted to be ranked in Managing Intellectual Property: IP Stars for 2019.
Jacqueline Murphy - June 17, 2019 IAM Patent 1000, 2019 We are delighted to be ranked highly recommended in ‘IAM 1000: The World’s Leading Patent ...
Nick Sutcliffe - November 14, 2018 Supreme Court decision signals bad news for patent holders The UK Supreme Court issued its decision today on the Warner Lambert vs Generics (UK) Ltd t/a ...